Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
growth source : Investors.biomarin.com save search
BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year
Published: 2023-11-01 (Crawled : 20:00) - investors.biomarin.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -3.58%
H: 0.93%
C: -1.64%
year total growth
BioMarin to Present Data Showing Long-Term Benefit of VOXZOGO® (vosoritide) on Growth in Children with Achondroplasia at 2023 European Society for Paediatric Endocrinology (ESPE) Meeting
Published: 2023-09-21 (Crawled : 14:30) - investors.biomarin.com
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -0.68%
H: 0.52%
C: -1.72%
voxzogo children achondroplasia meeting growth
BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues
Published: 2023-04-26 (Crawled : 20:00) - investors.biomarin.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.56%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -1.0%
H: 1.46%
C: 0.41%
total growth
BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business
Published: 2023-02-27 (Crawled : 22:00) - investors.biomarin.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -3.82%
H: 3.69%
C: 0.29%
voxzogo global year growth
BioMarin Announces Third Quarter 2022 Year-over-Year Total Revenue Growth of 24% (31% Excluding KUVAN®)
Published: 2022-10-26 (Crawled : 20:00) - investors.biomarin.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -2.68%
H: 0.0%
C: -4.35%
kuvan growth
BioMarin Announces the Ministry of Health, Labor and Welfare (MHLW) in Japan Granted Approval for VOXZOGO® (vosoritide) for Injection for the Treatment of Children with Achondroplasia, Whose Growth Plates are Not Closed
Published: 2022-06-21 (Crawled : 20:00) - investors.biomarin.com
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 0.66%
H: 6.95%
C: 4.08%
voxzogo treatment japan children granted approval injection growth achondroplasia
BioMarin Hires Pharmaceutical Industry Leaders in Marketing and Accounting to Fill Strategic Roles Supporting Company's Growth Plans
Published: 2022-05-05 (Crawled : 21:00) - investors.biomarin.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.11%
H: 2.28%
C: -0.39%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -10.81%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.32%
H: 0.75%
C: 0.2%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -1.18%
H: 1.07%
C: -2.15%
growth
BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates
Published: 2021-11-19 (Crawled : 15:30) - investors.biomarin.com
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 0.75%
H: 9.79%
C: 9.49%
fda drop fda approval injection children growth approval 25000 people voxzogo achondroplasia
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Published: 2021-06-25 (Crawled : 12:00) - investors.biomarin.com
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 0.66%
H: 1.39%
C: 0.55%
treatment europe drop positive children growth chmp achondroplasia
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.